Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 258Breast Neoplasms 218Lung Neoplasms 207Glioblastoma 202Head and Neck Neoplasms 193Prostatic Neoplasms 179Squamous Cell Carcinoma of Head and Neck 171Lymphoma 152Rectal Neoplasms 139Esophageal Neoplasms 125Central Nervous System Neoplasms 122Leukemia 111Brain Neoplasms 107Pancreatic Neoplasms 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Gliosarcoma 87Esophageal Squamous Cell Carcinoma 84Sarcoma 82Uterine Cervical Neoplasms 81Neoplasms 81Lymphoma, Follicular 81Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Non-Hodgkin 75Hodgkin Disease 74Glioma 68Burkitt Lymphoma 67Colorectal Neoplasms 66Leukemia, Lymphocytic, Chronic, B-Cell 63Astrocytoma 63Neoplasm Metastasis 60

Interventions

upadacitinib 1Surveys and Questionnaires 1Sodium Chloride 1Radiotherapy 1Injections, Intra-Articular 1Curcumin 1Arthroplasty, Replacement, Shoulder 1Arthroplasty, Replacement, Elbow 1Anastrozole 1Adrenal Cortex Hormones 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Joint Diseases × Radiotherapy × Clear all
NCT07478679 2026-03-23

Radiation to Treat Joint Damage Caused by Cancer Immunotherapy

University of Chicago

Phase 1 Not yet recruiting
20 enrolled

Arthritis, Joint Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡